Commentary

Pitfalls In Prescribing
Pitfalls In Prescribing
05/28/2019
Timothy H. Self, PharmD; Samantha Ellingson, PharmD, BCPS
When considering potential drug interactions with statin therapy, it is important to consider the hepatic pathways that could be negatively impacted with the addition of new medications.
05/28/2019
Pitfalls In Prescribing
Pitfalls In Prescribing
05/28/2019
Timothy H. Self, PharmD; Samantha Ellingson, PharmD, BCPS
When considering potential drug interactions with statin therapy, it is important to consider the hepatic pathways that could be negatively impacted with the addition of new medications.
05/28/2019
Pitfalls In Prescribing
Pitfalls In Prescribing
05/28/2019
Timothy H. Self, PharmD; Samantha Ellingson, PharmD, BCPS
When considering potential drug interactions with statin therapy, it is important to consider the hepatic pathways that could be negatively impacted with the addition of new medications.
05/28/2019
cardiovascular disease
cardiovascular disease
05/20/2019
In this commentary, Janet Wei, MD, discusses results of The Cardiovascular Inflammation Reduction Trial and the impact of anti-inflammatory agents on reducing cardiovascular risk.
05/20/2019
Travel Medicine
Travel Medicine
05/16/2019
When patients present with signs and symptoms that raise suspicion for meningitis, primary care providers should ask about recent travel to Hawaii.
05/16/2019
Travel Medicine
Travel Medicine
05/16/2019
When patients present with signs and symptoms that raise suspicion for meningitis, primary care providers should ask about recent travel to Hawaii.
05/16/2019
Travel Medicine
Travel Medicine
05/16/2019
When patients present with signs and symptoms that raise suspicion for meningitis, primary care providers should ask about recent travel to Hawaii.
05/16/2019
Travel Medicine
Travel Medicine
05/16/2019
When patients present with signs and symptoms that raise suspicion for meningitis, primary care providers should ask about recent travel to Hawaii.
05/16/2019
Cholesterol
Cholesterol
05/15/2019
In this commentary, Robert Rosenson, MD, explains that PCSK9 inhibitors may be a useful alternative therapy in lowering LDL cholesterol in individuals who are unable to tolerate statins at the doses...
05/15/2019
Cholesterol
Cholesterol
05/15/2019
In this commentary, Robert Rosenson, MD, explains that PCSK9 inhibitors may be a useful alternative therapy in lowering LDL cholesterol in individuals who are unable to tolerate statins at the doses...
05/15/2019